Drugs / B7H3 specific CAR T cell with IL-7Ra signaling domain
B7H3 specific CAR T cell with IL-7Ra signaling domain
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06221553 | Mar 2024 → Mar 2026 overdue | diffuse intrinsic pontine glioma | Chulalongkorn University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B7H3 specific CAR T cell with IL-7Ra signaling domain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06221553 ↗ |
| Modality | Cell therapy | “CAR T-cell” NCT06221553 ↗ |
| Route | Other | “delivered into the ventricular system” NCT06221553 ↗ |